Your browser doesn't support javascript.
loading
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, H-J; Berghold, A; Gerger, A.
Affiliation
  • Szkandera J; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Herzog S; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
  • Pichler M; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Stiegelbauer V; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Stotz M; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Schaberl-Moser R; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Samonigg H; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
  • Asslaber M; Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Lax S; Department of Pathology, General Hospital Graz West, Graz, Austria.
  • Leitner G; Department of Pathology, General Hospital of Leoben, Leoben, Austria.
  • Renner W; Clinical Institute of Medical and Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Lenz HJ; Division of Clinical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Berghold A; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
  • Gerger A; Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria.
Pharmacogenomics J ; 15(5): 391-6, 2015 Oct.
Article in En | MEDLINE | ID: mdl-25665511
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Colonic Neoplasms / Receptors, G-Protein-Coupled / Fluorouracil Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Colonic Neoplasms / Receptors, G-Protein-Coupled / Fluorouracil Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenomics J Year: 2015 Document type: Article